Scientific publications

Nature Communications, 2024

Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study

Xu X., Ai L., Hu K. et al.

Frontiers in Neuroscience, 2024

Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment

Ashok K., Martinez T., Sesen J. et al.

European Heart Journal, 2024

Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction

Reddy Y., Melenovsky V., Asokan A. et al.

Cardiovascular Research, 2024

Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis

Larsen J., Hegelund J., Pedersen M. et al.

Nature Communications, 2024

Non-human primate model of long-COVID identifies immune associates of hyperglycemia

Palmer C., Perdios C., Abdel-Mohsen M. et al.

Cell Metabolism, 2024

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females

Cordeiro B., Ahn J., Gawde S. et al.

Frontiers in Immunology, 2024

Comprehensive landscapes of the causal network between immunity and sarcopenia

Liu M., Wang J., Han Y. et al.

Nature Communications, 2024

A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes

Halama A., Zaghlool S., Thareja G. et al.

Clinical Cancer Bulletin, 2024

Causal associations of plasma proteins with lung squamous cell carcinoma risk: a proteome-wide Mendelian randomization and colocalization analysis

Wang Q., Xue X., Ling X. et al.

Journal of Bone and Mineral Metabolism, 2024

Olink and gut microbial metabolomics reveal new biomarkers for the prediction and diagnosis of PMOP

Wu R., Wu J., Jin H. et al.

Journal of Neuroinflammation, 2024

The differential proteomic response to ischemic stroke in appalachian subjects treated with mechanical thrombectomy

McLouth C., Maglinger B., Frank J. et al.

Journal of Proteome Research, 2024

Using Data-Driven Algorithms with Large-Scale Plasma Proteomic Data to Discover Novel Biomarkers for Diagnosing Depression

Ma S., Li R., Gong Q. et al.

Frontiers in Pharmacology, 2024

Novel therapeutic targets for primary open-angle glaucoma identified through multicenter proteome-wide mendelian randomization

Yuan W., Li J., Gao S. et al.

Frontiers in Immunology, 2024

Causal association between circulating inflammatory proteins and peripheral artery disease: a bidirectional two-sample Mendelian randomization study

Zhao J., Sun B., Huang S. et al.

Frontiers in Cardiovascular Medicine, 2024

Clinical characteristics and biomarkers feature analysis using a proteomics platform in young patients with acute coronary syndrome

Zhang K., Wang F., Yu Q. et al.

JACC: Basic to Translational Science, 2024

Proteomic Profile of the ICAM1 p.K56M HFpEF Risk Variant

Giro P., Filipp M., Zhang M. et al.

Science Translational Medicine, 2024

Natural killer cells promote neutrophil extracellular traps and restrain macular degeneration in mice

Dong X., Song Y., Liu Y. et al.

Respiratory Research, 2024

Integrated omics characterization reveals reduced cancer indicators and elevated inflammatory factors after thermal ablation in non-small cell lung cancer patients

Zhang X., Shao S., Song N. et al.

Frontiers in Immunology, 2024

Immunological characterization of IgG subclass deficiency reveals decreased Tregs and increased circulating costimulatory and regulatory immune checkpoints

Wågström P., Hjorth M., Appelgren D. et al.

American Journal of Transplantation, 2024

Trained immunity suppression determines kidney allograft survival

Jonkman I., Jacobs M., Negishi Y. et al.